| Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children (NCT01001169) | GlaxoSmithKline | 2009-10-01 |
| A Study to Characterize Event Related Potential Markers of Attentional Bias Towards Words and Images of Food (NCT01366508) | GlaxoSmithKline | 2009-10-01 |
| Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults (NCT00985673) | GlaxoSmithKline | 2009-10-01 |
| Regulatory Nebilet PMS (NCT01077661) | GlaxoSmithKline | 2009-10-01 |
| Post-operative Dental Pain Study Comparing Analgesic Efficacy (NCT01082081) | GlaxoSmithKline | 2009-10-01 |
| Cross-sectional Study on Human Papillomavirus Type Distribution in Adult Women Diagnosed With Cervical Cancer (NCT01221987) | GlaxoSmithKline | 2009-10-01 |
| Malignancy Meta Analysis for BRL49653 (NCT01195259) | GlaxoSmithKline | 2009-10-01 |
| A Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral SRT2104 Capsules Administered to Healthy Elderly Subjects for 28 Days (NCT00964340) | GlaxoSmithKline | 2009-10-01 |
| Exploratory Subjective Sleep Study of a Prototype Nasal Dilator (NCT01122849) | GlaxoSmithKline | 2009-10-01 |
| Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP) (NCT00908037) | GlaxoSmithKline | 2009-09-30 |
| Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children (NCT00972517) | GlaxoSmithKline | 2009-09-29 |
| 28 Day Repeat Dose in Cystic Fibrosis Patients (NCT00903201) | GlaxoSmithKline | 2009-09-28 |
| Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents (NCT00963937) | GlaxoSmithKline | 2009-09-28 |
| GSK618334 Repeat Dose Study (NCT01036061) | GlaxoSmithKline | 2009-09-28 |
| A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT01009463) | GlaxoSmithKline | 2009-09-25 |
| To Characterize the Performance of the Nasal Dilator Strip in Lowering Nasal Resistance During Sleep, Promoting Nasal Route Breathing and Reducing the Signs and Symptoms of Sleep Disordered Breathing in a Group of Chronic Nocturnal Nasal Congestion Sufferers Who Report Trouble With Their Sleep. (NCT03105297) | GlaxoSmithKline | 2009-09-25 |
| A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT01017952) | GlaxoSmithKline | 2009-09-25 |
| Clinical Study to Test a New Drug to Treat Major Depression (NCT00976560) | GlaxoSmithKline | 2009-09-25 |
| Effects of Repeat Dosing of GSK1521498 (NCT00976105) | GlaxoSmithKline | 2009-09-22 |
| Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects (NCT00947115) | GlaxoSmithKline | 2009-09-22 |
| Phase 0 Microdose Study (NCT00975936) | GlaxoSmithKline | 2009-09-21 |
| GSK962040 Drug-drug Interaction Study With Ketoconazole (NCT01039974) | GlaxoSmithKline | 2009-09-18 |
| A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets Manufactured at Crawley and Aranda (NCT01371682) | GlaxoSmithKline | 2009-09-18 |
| Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate is Processed by the Body in Healthy Caucasian, Japanese, Korean and Chinese Subjects (NCT01000597) | GlaxoSmithKline | 2009-09-17 |
| Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis (NCT01036022) | GlaxoSmithKline | 2009-09-15 |
| Study to Evaluate Immunogenicity & Safety of an Investigational Influenza Vaccine in Adults (NCT00975884) | GlaxoSmithKline | 2009-09-14 |
| Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in Elderly (NCT00968890) | GlaxoSmithKline | 2009-09-12 |
| Safety and Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A) (NCT00964158) | GlaxoSmithKline | 2009-09-10 |
| Safety, Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A) (NCT00971321) | GlaxoSmithKline | 2009-09-10 |
| Paxil CR Bioequivalence Study Brazil (NCT01316926) | GlaxoSmithKline | 2009-09-09 |
| Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults (NCT00968539) | GlaxoSmithKline | 2009-09-08 |
| Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1) (NCT00971425) | GlaxoSmithKline | 2009-09-08 |
| Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults (NCT00968526) | GlaxoSmithKline | 2009-09-08 |
| GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease (NCT00950807) | GlaxoSmithKline | 2009-09-01 |
| Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK 134612 (NCT00974363) | GlaxoSmithKline | 2009-09-01 |
| Study to Assess Cardiac Conduction of GSK1349572 (NCT00996021) | GlaxoSmithKline | 2009-09-01 |
| Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine (NCT01435941) | GlaxoSmithKline | 2009-09-01 |
| Insulin Resistance as Primary Pathogenesis in Newly Diagnosed, Drug naïve Type 2 Diabetes Patients in Korea (NCT01154244) | GlaxoSmithKline | 2009-09-01 |
| Pharmacokinetics, Effect of Food, Safety and Tolerability of a New Tablet Formulation of GSK1144814 in Healthy Subjects (NCT01090440) | GlaxoSmithKline | 2009-09-01 |
| Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery (NCT01390896) | GlaxoSmithKline | 2009-09-01 |
| A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis (NCT01231464) | GlaxoSmithKline | 2009-09-01 |
| Efficacy of Potassium Nitrate Solution in Reducing Dentinal Hypersensitivity (NCT01115452) | GlaxoSmithKline | 2009-09-01 |
| A Phase I/II, a Single Arm, Open-label Study of Ofatumumab (GSK1841157) in Patients With Previously Treated Chronic Lymphocytic Leukemia (NCT01077622) | GlaxoSmithKline | 2009-09-01 |
| A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy (NCT00891761) | GlaxoSmithKline | 2009-09-01 |
| Efficacy and Safety Study in Subjects With Asthma (NCT00980200) | GlaxoSmithKline | 2009-09-01 |
| An Evaluation of Two Novel Nasal Strip Prototypes on Nasal Patency (NCT01105949) | GlaxoSmithKline | 2009-09-01 |
| A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine (NCT00976391) | GlaxoSmithKline | 2009-09-01 |
| Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390 (NCT00996216) | GlaxoSmithKline | 2009-09-01 |
| Dose-Escalation Study of GSK2126458 (NCT00972686) | GlaxoSmithKline | 2009-08-31 |
| Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteers (NCT01030939) | GlaxoSmithKline | 2009-08-27 |
| Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation (NCT00964106) | GlaxoSmithKline | 2009-08-26 |
| Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants (NCT00969228) | GlaxoSmithKline | 2009-08-25 |
| Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK134612 (NCT00955682) | GlaxoSmithKline | 2009-08-25 |
| Safety, Blood Levels, Drug Interaction and Effects of Repeated Doses of GSK1034702 (NCT00950586) | GlaxoSmithKline | 2009-08-24 |
| A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects (NCT00955773) | GlaxoSmithKline | 2009-08-17 |
| A Study to Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced Melanoma (NCT00942162) | GlaxoSmithKline | 2009-08-14 |
| GSK2190915 Safety and Pharmacokinetic Study in Healthy Japanese Subjects (NCT00955383) | GlaxoSmithKline | 2009-08-14 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Type 2 Diabetics (NCT01013766) | GlaxoSmithKline | 2009-08-13 |
| Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age (NCT00970307) | GlaxoSmithKline | 2009-08-13 |
| Safety Study of Foretinib (GSK1363089) in Adults With Liver Cancer (NCT00920192) | GlaxoSmithKline | 2009-08-12 |
| Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment (NCT00935831) | GlaxoSmithKline | 2009-08-12 |
| Combination Study of GSK1120212 With Gemcitabine in Subjects With Solid Tumors (NCT01428427) | GlaxoSmithKline | 2009-08-12 |
| Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults (NCT00951041) | GlaxoSmithKline | 2009-08-11 |
| Long-term Follow-up Study of Children Previously Primed With GSK Pneumococcal Vaccine (GSK1024850A) and of Unprimed Children (NCT00950833) | GlaxoSmithKline | 2009-08-10 |
| Gynaecological Follow-up of a Subset of 580299/008 (NCT00122681) Study Subjects (NCT00937950) | GlaxoSmithKline | 2009-08-05 |
| A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects. (NCT00938158) | GlaxoSmithKline | 2009-08-05 |
| Safety and Reactogenicity of GSK Biologicals' Inactivated Poliomyelitis Vaccine (IPV) (Poliorix) in Infants (NCT00937404) | GlaxoSmithKline | 2009-08-04 |
| Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Indian Infants (NCT00938327) | GlaxoSmithKline | 2009-08-03 |
| Meta-analysis - Eltrombopag (NCT01235988) | GlaxoSmithKline | 2009-08-01 |
| Indirect Comparison Between Eltrombopag & Romiplostim (NCT01236014) | GlaxoSmithKline | 2009-08-01 |
| Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm (NCT00911300) | GlaxoSmithKline | 2009-08-01 |
| Study in Neuropathic Pain Patients With Peripheral Nerve Injury (NCT00969059) | GlaxoSmithKline | 2009-08-01 |
| Utility and Work Productivity Data for Economic Evaluation of Breast Cancer Therapies in the Netherlands and Sweden (NCT01209091) | GlaxoSmithKline | 2009-08-01 |
| Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone) (NCT01332409) | GlaxoSmithKline | 2009-08-01 |
| Evaluation of a Test Mouthwash and Dentifrice Regimen in an In-situ Model of Dental Erosion (NCT01128972) | GlaxoSmithKline | 2009-08-01 |
| Fluticasone Propionate-salmeterol Combination Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01381471) | GlaxoSmithKline | 2009-08-01 |
| A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110mcg Among Vietnamese Adult Patients With Established Perennial Allergic Rhinitis (NCT01270958) | GlaxoSmithKline | 2009-08-01 |
| Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly (NCT00938392) | GlaxoSmithKline | 2009-07-30 |
| Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of GSK573719 (LAMA) and GW642444 (LABA)Administered Individually and Concurrently in Healthy Japanese Subjects (NCT00976144) | GlaxoSmithKline | 2009-07-29 |
| Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study (NCT00937846) | GlaxoSmithKline | 2009-07-15 |
| Single Dose Study of Controlled-Release Paroxetine Tablets in Healthy Japanese Male Subjects (NCT00938184) | GlaxoSmithKline | 2009-07-14 |
| Safety & Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A (NCT00920218) | GlaxoSmithKline | 2009-07-14 |
| Immunogenicity & Safety Study of Fluviral® (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years (NCT00929331) | GlaxoSmithKline | 2009-07-11 |
| A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures (NCT01199757) | GlaxoSmithKline | 2009-07-10 |
| Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer (NCT00866528) | GlaxoSmithKline | 2009-07-09 |
| Safety Escalating Repeat IV, in Stroke Patients (NCT00833989) | GlaxoSmithKline | 2009-07-08 |
| Subcutaneous Administration of Otelixizumab to T1DM Patients (NCT00946257) | GlaxoSmithKline | 2009-07-08 |
| G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine) (NCT01205178) | GlaxoSmithKline | 2009-07-02 |
| A Study to Evaluate the Effect of Repeat Doses of GW870086X in Mild to Moderate Asthmatics (NCT00945932) | GlaxoSmithKline | 2009-07-01 |
| A Pharmacokinetic Study of an Experimental Paracetamol Formulation (NCT01476176) | GlaxoSmithKline | 2009-07-01 |
| Paracetamol With Caffeine to Treat Episodic Tension Type Headache (NCT01755702) | GlaxoSmithKline | 2009-07-01 |
| DDI Study of Etravirine and GSK1265744 (NCT00920296) | GlaxoSmithKline | 2009-07-01 |
| Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01331694) | GlaxoSmithKline | 2009-07-01 |
| GSK1349572 Proton Pump Inhibitor Drug Interaction and Supratherapeutic Dose Study (NCT00942136) | GlaxoSmithKline | 2009-07-01 |
| Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian Children (NCT01159925) | GlaxoSmithKline | 2009-07-01 |
| Analysis of Expression of Specific Markers in Hepatocellular Carcinoma (NCT00858000) | GlaxoSmithKline | 2009-07-01 |
| Prophylactic Efficacy of Relenza Against Influenza A and B (NCT01156701) | GlaxoSmithKline | 2009-07-01 |
| Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76 (NCT01914770) | GlaxoSmithKline | 2009-07-01 |
| Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer (NCT00871403) | GlaxoSmithKline | 2009-07-01 |
| Treatment With Pazopanib for Neoadjuvant Breast Cancer (NCT00849472) | GlaxoSmithKline | 2009-07-01 |